| Mr Jerrold Howard Seckler, MD | |
|
880 W. Central Road, Suite 5200, Arlington Heights, IL 60005 | |
| (847) 259-2410 | |
| (847) 259-8603 |
| Full Name | Mr Jerrold Howard Seckler |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 880 W. Central Road, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982676342 | NPI | - | NPPES |
| 1615843 | Other | IL | BCBS |
| C42156 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 036047545 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jerrold Howard Seckler, MD 880 W. Central Road, Suite 5200, Arlington Heights, IL 60005 Ph: (847) 259-2410 | Mr Jerrold Howard Seckler, MD 880 W. Central Road, Suite 5200, Arlington Heights, IL 60005 Ph: (847) 259-2410 |
News Archive
Two drug combinations that simultaneously block two major signaling pathways downstream of the protein KRAS, which is aberrantly active in most pancreatic cancers, may provide a new treatment option for patients with this disease, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
As the COVID-19 pandemic continues to challenge existing health networks, a new study published on the preprint server medRxiv in October 2020 reports on a strategy to address existing health care disparities in rural and urban areas of the USA. This should draw attention to the need for more such systems to ensure proper rural healthcare in the current and future pandemics.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.
Virtual Pharma Rep™, a new company built by pharmaceutical industry veterans, today announced their launch to market. Virtual Pharma Rep™ delivers a patent pending, virtual sales process that revolutionizes expensive pharmaceutical sales.
› Verified 4 days ago
Mr. David Aaron Guthman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Dr. April Adams Szafran, MD, PHD Urology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Phuong N Huynh, MD, MPH Urology Medicare: Accepting Medicare Assignments Practice Location: 2101 S Arlington Heights Rd Ste 150, Arlington Heights, IL 60005 Phone: 630-790-1221 | |
Dr. Michael James Ross, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Humberto Joseph Martinez-suarez, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Sarah Martin, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 2101 S Arlington Heights Rd Ste 150, Arlington Heights, IL 60005 Phone: 847-439-4343 Fax: 847-439-4510 |